Peptic Esophagitis (Reflux Esophagitis)

11/01/2003 - "In adult studies, proton pump inhibitors (PPIs) are highly effective in relieving reflux symptoms and healing reflux esophagitis. "
01/01/2013 - "Proton pump inhibitors (PPIs) are widely used as the mainstay of treatment for erosive reflux esophagitis, based on the excellent results obtained in clinical trials. "
11/01/1997 - "Proton pump inhibitor (PPI) is very effective in the initial treatment of reflux esophagitis. "
01/01/2009 - "Reflux esophagitis, which was seen in five patients, was treated successfully with a proton pump inhibitor. "
01/01/2022 - "Proton pump inhibitors (PPIs) were more effective for reflux esophagitis at 5-year follow-up (P = 0.03) than after 1 year (P = 0.08). "

10/01/1988 - "Omeprazole is a highly effective treatment for peptic esophagitis. "
01/01/2014 - "The use of omeprazole significantly improved sleep disturbances caused by reflux esophagitis, and this effect was not observed when the PPI was withdrawn. "
02/01/1992 - "In doses ranging from 20-60 mg once daily, omeprazole has proved to be effective in the short-term treatment of reflux esophagitis, even in patients resistant to treatment with H2-receptor antagonists. "
01/01/2009 - "To compare the efficacy of different omeprazole formulations on gastric acid secretion measured by intragastric and esophageal pH monitoring in patients with reflux esophagitis. "
07/01/2001 - "Alternate-day, long-term treatment with omeprazole may be adequate to maintain remission in patients with reflux esophagitis. "

01/01/2017 - "The establishment of a new treatment for reflux esophagitis taking advantage of the rapid and potent acid-suppressive effects is awaited."
10/01/2004 - "pylori eradication does not have any effect on gastroesophageal acid reflux in patients with reflux esophagitis 3 months after eradication, but significant improvement is achieved in some reflux associated symptoms."
11/01/1981 - "Since there is no "gold standard" for the evaluation of reflux esophagitis, some of the tests designed to evaluate reflux and the patient's reaction to acid in the esophagus include the acid infusion test, the standard acid reflux test, the acid clearance test, and 24-hour pH monitoring. "
01/01/2022 - "The aim of this study was to assess the impact of a Scutellariae Radix and Citri Reticulatae Pericarpium mixture (SC) on esophageal mucosal injury in rats with chronic acid reflux esophagitis (CARE). "
01/01/2020 - "This study examined the predictive role of the endoscopic findings, including the flap valve grade for pathologic acid exposure (PAE) to establish an endoscopic prediction model in patients with neither reflux esophagitis nor HH. "

01/01/1997 - "Ranitidine 150 mg bid and 300 mg bid are safe and effective treatments in the prevention of reflux esophagitis relapse."
01/01/1997 - "To compare the efficacy and safety of long term use of ranitidine 150 mg bid, 300 mg bid and placebo in prevention of endoscopic and symptomatic relapse of reflux esophagitis in an international, double-blind, placebo controlled, parallel group study. "
01/01/1997 - "Prevention of relapse in reflux esophagitis: a placebo controlled study of ranitidine 150 mg bid and 300 mg bid."
08/01/1986 - "In a randomized multicentre study 96 patients with mild to moderate types of reflux esophagitis (stages I and II according to Savary-Miller) the effect of 150 mg ranitidine b.i.d. "
12/18/1982 - "Thirty-eight patients with erosive-ulcerative reflux esophagitis were treated in an open trial with the histamine-H2-receptor antagonist ranitidine (150 mg twice daily). "

01/01/2017 - "In the clinical trial data, vonoprazan is very effective for reflux esophagitis. "
02/01/2022 - "After switching patients to vonoprazan, the endoscopic findings of reflux esophagitis were significantly improved (p = .033), and six patients (60%) achieved mucosal healing. "
12/01/2016 - "Vonoprazan is an effective treatment for ARDs that is especially effective in healing reflux esophagitis and for H. "
10/01/2022 - "However, we found that in certain conditions like a reduction in the price of vonoprazan and in patients with severe reflux esophagitis these could be cost-effective."
01/01/2022 - "They also recommend vonoprazan or PPI as an initial treatment for mild reflux esophagitis and recommended PPI and proposed vonoprazan as maintenance treatment. "

02/01/1998 - "Lansoprazole was safe and effective for the treatment of reflux esophagitis in this trial. "
08/01/2009 - "Long-term efficacy of lansoprazole in preventing relapse of erosive reflux esophagitis."
09/01/2019 - "This study was conducted to evaluate the cost-effectiveness of a P-CAB, VPZ vs. a PPI, lansoprazole (LPZ), for the acute medical treatment of reflux esophagitis. "
01/01/2008 - "The demographic characteristics and health-related quality of life in a large cohort of reflux esophagitis patients in Japan with reference to the effect of lansoprazole: the REQUEST study."
02/01/1998 - "This study indicates that the optimum daily dose of lansoprazole for reflux esophagitis is 30 mg."

11/01/2000 - "Parenteral pantoprazole is effective in the treatment of reflux esophagitis. "
12/01/2012 - "Efficacy of S-pantoprazole 20 mg compared with pantoprazole 40 mg in the treatment of reflux esophagitis: a randomized, double-blind comparative trial."
12/01/2012 - "The purpose of this study was to compare the efficacy and safety of S-pantoprazole 20 mg versus pantoprazole 40 mg for treatment of reflux esophagitis. "
12/01/2012 - "The healing rate of reflux esophagitis was 85 % at 4 weeks and 94 % at 8 weeks in the S-pantoprazole group, which did not differ from those in the pantoprazole group (84 and 97 %, respectively). "
03/01/2005 - "Two hundred twenty-seven patients with endoscopically proven reflux esophagitis were treated for 8 weeks with pantoprazole, 40 mg daily. "

01/01/2017 - "Conclusion Twice-daily treatment with rabeprazole improved the subjective symptoms and health-related quality of life in patients with refractory reflux esophagitis more effectively than the standard once-daily dose."
04/01/2012 - "Efficacy of twice-daily rabeprazole for reflux esophagitis patients refractory to standard once-daily administration of PPI: the Japan-based TWICE study."
05/01/2019 - "Furthermore, rabeprazole sodium (RS) administration, reflux esophagitis (RE), and intraoperative and postoperative complications were also evaluated. "
01/01/2017 - "Therapeutic Response to Twice-daily Rabeprazole on Health-related Quality of Life and Symptoms in Patients with Refractory Reflux Esophagitis: A Multicenter Observational Study."
05/01/2012 - "Treatment with rabeprazole resulted in a decrease from 18.6 at baseline to 6.7 at week 8 in underweight reflux esophagitis subjects, and from 15.0 to 6.3 in underweight NERD patients. "

02/01/1992 - "Recent data also show that long-term treatment with famotidine seems to be effective in preventing recurrence in most patients with healed reflux esophagitis. "
12/01/1993 - "Efficacy of famotidine 20 mg twice a day versus 40 mg twice a day in the treatment of erosive or ulcerative reflux esophagitis."
01/01/1987 - "This study was conducted to determine whether the use of a new H2-antagonist, famotidine, could prevent recurrence of reflux esophagitis among such children. "
01/01/1987 - "Further studies should be conducted to define the role of famotidine in the treatment of reflux esophagitis."
01/01/1987 - "An open-labeled study of once-daily administration of 40 mg famotidine was conducted in 24 patients with endoscopically confirmed reflux esophagitis. "

06/09/1989 - "The purpose of this study was to determine the efficacy of sucralfate in the treatment of peptic esophagitis in children. "
01/01/1989 - "Efficacy of sucralfate in refractory reflux esophagitis. "
01/01/1992 - "This study does not support the commonly used combination of sucralfate and H2-receptor antagonists in reflux esophagitis."
01/01/1991 - "This article reviews a number of clinical studies evaluating sucralfate in the treatment of reflux esophagitis. "
01/01/1991 - "Clinical studies of sucralfate in reflux esophagitis. "

09/01/2004 - "Long-term maintenance PPI therapy is reported to be very effective in maintaining the remission of reflux esophagitis for up to 5 years. "
01/01/2012 - "PPI maintenance therapy was less effective in patients with more severe reflux esophagitis of grades C and D (OR: 0.027; 95% CI: 0.010-0.077) and negative H. "
05/01/1991 - "We conclude that anti-secretory therapy is more effective than mucosal protection in the treatment of refractory peptic esophagitis."
12/01/2010 - "In patients requiring maintenance therapy, PPIs appear to be well tolerated and effective in maintaining remission of reflux esophagitis and reflux symptoms."
12/01/2010 - "Five studies evaluated the efficacy of PPI maintenance therapy (6- to 90-month follow-up) in pediatric patients after healing of reflux esophagitis. "

11/01/2022 - "Marked improvement of severe reflux esophagitis following proximal gastrectomy with esophagogastrostomy by the right gastroepiploic vessels-preserving antrectomy and Roux-en-Y biliary diversion."
12/20/2021 - "Transposition of the jejunojejunostomy was an effective treatment for medication-resistant severe reflux esophagitis after total gastrectomy."
01/01/2023 - "This study aimed to evaluate the utility and complications of ultra-short cecum (USC) in the reconstruction of digestive tract after total gastrectomy (TG) for the alleviation of reflux esophagitis and to determine its effect on long-term nutritional status. "
01/01/2021 - "Studies comparing the incidence of reflux esophagitis (RE) and patients' quality of life (QoL) when using circular stapler (CS) and linear stapler (LS) in esophagojejunostomy (EJS) after laparoscopic total gastrectomy (LTG) are rare, and certainly there are not enough to make a definitive decision on best practice. "
01/01/1982 - "Experimental studies of reflux esophagitis following total gastrectomy in rats-pathogenesis and treatment."

03/01/1993 - "Nissen fundoplication is effective in patients with reflux esophagitis who have adequate esophageal motility."
04/01/1974 - "Proceedings: Nissen fundoplication without crural repair: a cure for reflux esophagitis."
04/01/1993 - "This study evaluates the clinical and endoscopic long-term results of Nissen fundoplication in reflux esophagitis. "
10/01/2021 - "Factors affecting the treatment outcomes of laparoscopic fundoplication for erosive reflux esophagitis: findings of esophageal pathological function tests."
11/01/2020 - "Fundoplication after LECS may be an approach for the prevention of postoperative reflux esophagitis. "

03/01/2006 - "The authors concluded that although symptoms improved in more than half of infants with reflux esophagitis followed longitudinally, esophageal mucosal histology remained abnormal at the 1-yr evaluation in the absence of pharmacotherapy. "
03/01/2006 - "Although symptoms improved in more than half of the infants with reflux esophagitis followed longitudinally for 1 yr without pharmacotherapy, histology remained abnormal."
03/01/2006 - "Natural history of infant reflux esophagitis: symptoms and morphometric histology during one year without pharmacotherapy."
03/01/2005 - "Reflux esophagitis secondary to chemotherapy detected by serial FDG-PET."
07/14/1993 - "[Drug therapy of ulcer and reflux esophagitis. "

01/01/2017 - "The gastric-tube esophagectomy is superior to the whole-stomach approach, as it is associated with a lower incidence of postoperative reflux esophagitis and thoracic stomach syndrome. "
11/01/2013 - "The aim of the present study was to evaluate whether gastropyloric motility influences the pathogenesis of reflux esophagitis after an esophagectomy. "
01/01/2019 - "Despite the high incidence of reflux esophagitis, there are few reports of antireflux modifications for minimally invasive Ivor-Lewis esophagectomy. "
01/01/2019 - "We used immunohistochemistry and quantitative polymerase chain reaction to assess EMT markers in the columnar-lined esophagus of rats with surgically induced reflux esophagitis and in esophagectomy specimens from patients with BE. "
03/01/2017 - "Among patients who undergo gastric tube reconstruction after esophagectomy, it is generally accepted that the incidence of reflux esophagitis (RE) is significantly lower in patients with neck anastomosis than in those with intrathoracic anastomosis. "